Similar Search Results

The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany

Blankart, Katharina Elisabeth; Stargardt, Tom - In: Health Economics 29 (2020) S1, pp. 63-82

Payers are increasingly calling for the value of new drugs to be measured explicitly. We analyze how the availability of drug quality ratings by health technology assessment (HTA) agencies affects the adoption of new drugs by physicians in Germany. We combine data from drug quality ratings,...

Persistent link: https://www.econbiz.de/10012428860

Global financial system outcomes after 2008: A longitudinal comparison

Ter-Mkrtchyan, Ani; Franklin, Aimee L. - In: Economies 8 (2020) 1, pp. 1-14

This paper examines how the governance context and financial institutions may relate to different aspects of a country's financial system before and after a crisis. Using a fixed-effects regression model for panel data and a comparative perspective, we assess longitudinal trends in the...

Persistent link: https://www.econbiz.de/10013199653

On the political decision of audit market regulation: Empirical evidence of audit firm tenure and maximum durations within the European Union

Widmann, Markus; Follert, Florian; Wolz, Matthias - In: Economies 9 (2021) 2, pp. 1-24

. Regarding the latest international financial crisis, the EU responded, among other things, with comprehensive regulation of the … threshold-or is it simply arbitrary? Our aim is to evaluate the audit market reform by the European Union (EU) (Regulation (EU … interest entities (Regulation (EU) No 537/2014, Article 17). Based on a unique dataset of 11,834 firm observations from all …

Persistent link: https://www.econbiz.de/10013199817

Parallel imports under a manufacturer rebate and a price freeze: Evidence from Germany

Birg, Laura - In: Health Economics 32 (2022) 2, pp. 302-323

I study the effect of a change in the mandatory manufacturer rebate and a price freeze on wholesale prices for pharmaceuticals on competition by parallel imports. First, I analyze the effect of a manufacturer rebate on competition by parallel imports in a two‐country model. Second, I exploit a...

Persistent link: https://www.econbiz.de/10014503575